Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ZVRA
#2833
Zevra Therapeutics, Inc. Common Stock
9.690
0
USD
-0.31%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
-0.31%
Aylık Değişim
-8.04%
6 aylık değişim
-8.93%
Yıllık Değişim
-8.93%
Önceki Kapanış
9.720
0
Open
9.750
0
Bid
Ask
Low
9.690
0
High
9.755
0
Hacim
78
Piyasalar
ABD Borsası
Sağlık Hizmetleri
ZVRA
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
28.38 M
34.42 M
34.54 M
43.43 M
54.12 M
58.71 M
—
Valuation ratios
Enterprise value
—
—
—
297.32 M
477.84 M
526.86 M
2.01 B
Price to earnings ratio
—
—
—
-5.26
-3.66
6.64
-14.66
Price to sales ratio
—
—
—
8.82
16.34
4.82
57.18
Price to cash flow ratio
—
—
—
-7.22
-5.54
-321.07
-376.89
Price to book ratio
—
—
—
3.91
9.72
3.32
10.17
Enterprise value to EBITDA ratio
—
—
—
-5.12
-4.81
5.18
25.4
Profitability ratios
Return on assets %
-1.14
-0.06
-0.36
-0.27
-0.59
0.29
0.31
Return on equity %
0.19
-0.07
-0.48
-0.74
-2.66
0.54
0.64
Return on invested capital %
-551.89
272.36
-707.95
-249.94
-352.06
-254.33
-354.14
Gross margin %
100
100
96.72
89.28
42.18
84.52
328.46
Operating margin %
-42.21
26.98
-406.44
-180.63
-368.47
-59.12
-257.57
EBITDA margin %
-40.16
27.87
-42.2
-180.26
-367.86
84
142.24
Net margin %
-96.03
-29.86
-397.24
-167.69
-446.85
78.17
307.03
Liquidity ratios
Quick ratio
—
—
—
1.05
2.47
5.63
24.94
Current ratio
1.11
27.2
7.93
1.18
2.53
5.68
25.17
Inventory turnover
—
—
—
—
2.31
8.89
10.04
Asset turnover
1.22
0.4
0.08
0.19
0.13
0.46
0.46
Solvency ratios
Debt to assets ratio
6.21
0.01
0.12
0.25
0.34
0.22
1.06
Debt to equity ratio
-1.05
0.01
0.16
0.71
1.52
0.41
2.92
Long term debt to total assets ratio
6.04
0
0.11
0.25
0.33
0.22
1.03
Long term debt to total equity ratio
-1.02
0
0.15
0.69
1.5
0.4
2.84
Per share metrics
Operating cash flow per share
—
0.35
-0.54
-0.95
-1.51
-0.03
0.19
EBIT per share
—
0.26
-1.23
-1.4
-1.59
0.28
0.35
EBITDA per share
—
0.27
-0.13
-1.4
-1.88
1.56
0.61
Total debt per share
—
0.05
0.41
1.23
1.3
1.1
2.78
Cash per share
—
3.77
2.4
1.91
1.5
3.34
9.94
Net current asset value per share
—
3.87
2.7
2.45
1.86
3.89
11.21
Tangible book value per share
—
4.27
2.49
-0.34
-0.74
2.51
6.83
Working capital per share
—
3.72
2.36
0.37
1.12
3.21
9.79
Book value per share
—
4.27
2.49
1.74
0.86
2.7
6.8
Haberler
BTIG, Zevra Therapeutics hissesini Miplyffa görünümüyle al önerisiyle kapsama aldı
BTIG initiates Zevra Therapeutics stock with buy on Miplyffa outlook
Micron and BioNTech among market cap stock movers on Tuesday
Micron and Palantir among market cap stock movers on Tuesday
ExxonMobil, Chevron edge lower premarket; Hewlett Packard Enterprise climbs
ExxonMobil ve Chevron düştü; Hewlett Packard Enterprise yükseldi
Guggenheim, Zevra Therapeutics için hedef fiyatı 23 dolara yükseltti
Guggenheim raises Zevra Therapeutics stock price target to $23
Zevra Therapeutics 4Ç 2025 kazancı tahminleri aştı
Earnings call transcript: Zevra Therapeutics Q4 2025 earnings beat forecasts
Zevra Therapeutics, Inc. (ZVRA) Q4 2025 Earnings Call Transcript
Zevra Therapeutics kazancı $0,14 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek